Richard Sutin

Richard Sutin

Director/Board Member at MEDICENNA THERAPEUTICS CORP.

Net worth: 5 750 $ as of 2026-07-30

Commercial Services
Health Technology
Finance

Profile

Richard Salter Sutin is currently Chairman at The Bullet ID Corp., Director at Medicenna Therapeutics Corp.
starting in 2026, and a Member of The Law Society of Upper Canada since 1977.
Former roles include President & Chief Executive Officer at Aylen Capital, Inc. in 2020, Director at Denninghouse, Inc., Director at Chieftain Metals Corp.
in 2013, Director at Nesscap Energy, Inc., Interim Secretary at Telesta Therapeutics, Inc., Secretary at Spackman Equities Group, Inc., Senior Partner at Ogilvy Renault LLP, Senior Partner at Norton Rose OR LLP, and Senior Partner at Norton Rose Fulbright Canada LLP from 1983 to 2018.
Education includes undergraduate and graduate degrees from York University and an undergraduate degree from Osgoode Hall Law School conferred in 1975.

Known holdings in public companies

CompanyDateNumber of sharesValuationValuation date
2026-05-27 23,000 ( 0.02% ) 5 750 $ 2026-07-30

Richard Sutin active positions

CompaniesPositionStart
MEDICENNA THERAPEUTICS CORP. Director/Board Member 2026-02-11
Corporate Officer/Principal 1976-12-31
Chairman -

Former positions of Richard Sutin

CompaniesPositionEnd
DEEPSPATIAL INC. Chief Executive Officer 2020-12-21
Corporate Officer/Principal 2018-11-30
Corporate Officer/Principal 2012-06-13
Director/Board Member 2012-06-12
CHIEFTAIN METALS CORP Director/Board Member -
See the detail of Richard Sutin's experience

Training of Richard Sutin

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

Connections

88

1st degree connections

14

1st degree companies

Male

Female

Members of the board

Executives

Linked companies

Private companies14

Health Technology

Retail Trade

Finance

Non-Energy Minerals

Commercial Services

Consumer Services

Commercial Services

Consumer Services

Electronic Technology

Commercial Services

Finance

Commercial Services

Health Technology

Technology Services